According to a statement from Police Headquarters, a 57-year-old man in the town of Alicante was arrested by National Police officers on suspicion of opening an account in his ex-partner’s name on a popular online e-commerce platform and making 8,700 euros in purchases without paying for them.

After a woman complained that she had been duped by a reputable online e-commerce platform after receiving many letters demanding payment for multiple orders that totalled over 8,700 euros, the inquiry got underway.

The victim said that because she had not made any purchases or registered for an account on the platform, she was unable to identify these orders as her own.

Investigators were able to identify the suspected fraudster—a man the victim had previously had a romantic relationship with—after examining all of the victim’s submitted papers and gathering a number of pertinent pieces of information.

According to the same sources, the agents’ investigations revealed that the suspect, who is of Spanish descent, created an account using his ex-partner’s personal information, provided false bank information, and designated his own house as the delivery address for the shipments.

All of the purchases would have been done by the same individual because the investigators were positive that the user and creator of the account on the popular platform was the subject of the inquiry. After being recognised, he was found and taken into custody on suspicion of fraud and document fabrication.

The business is offering tickets starting at €9 on March 6 for a summer trip between Madrid, Valladolid, and the Levante peninsula’s Valencia, Alicante, and Murcia, with stops at Elche, Cuenca, Albacete, and Segovia in between.

Tickets prices for high-speed travel start at €9 and are available on the OUIGO website https://www.ouigo.com/es/ and app. March 3, 2025, Madrid. OUIGO, the operator of high-speed trains, is aware that some possibilities are too good to pass up.

For this reason, it is starting to sell tickets for travel between June 30 and September 14 on its routes between Madrid, Valladolid, and its destinations in the Levante at just €9 on March 6 at 12:00 p.m.

Since it’s never been so simple to travel swiftly, comfortably, and affordably, these business destinations will be closer than ever this summer, allowing you to plan ahead for those ideal vacations with friends, family, or alone. Children under three years old travel free of charge, provided they are accompanied by an adult. From a tapas tour in Alicante to a sunset on Valencia’s Malvarrosa beach, to the ancient beauty of Murcia or the wine of Valladolid. OUIGO offers visitors three unique experiences this summer: the heritage of Castilian cities like Segovia, the Mediterranean spirit of the Levantine coast, and the customs of Albacete, Elche, and Cuenca.

The problem is that you can plan the trip today, so why wait until tomorrow? Nearer than before: High-speed connections between Madrid, Valladolid, Valencia, Alicante, and Murcia There will be 20 daily connections available to travellers, ensuring comfort and flexibility. Four trips will depart at 7:15 a.m., 11:15 a.m., 1:15 p.m., and 5:15 p.m. in each way between Madrid and Valencia, and at 7:27 a.m., 10:27 a.m., 5:28 p.m., and 8:27 p.m. in the other route. The train will leave Alicante at 2:00 pm and 6:00 pm, and passengers will have two trips between Madrid and Alicante, with a stop in Albacete, at 10:15 am and 8:15 pm. There will also be two additional routes between Madrid and Murcia that stop at Albacete and Elche. These routes will depart at 8:15 a.m. and 4:15 p.m. and return at 12:39 p.m. and 8:39 p.m. Lastly, a round-trip service has been added to the Valladolid-Valencia routes, which depart at 8:00 p.m. and return at 2:51 p.m. with stops in Cuenca, Madrid, and Segovia; the Valladolid-Alicante routes, which depart at 1:00 p.m. and return at 7:53 a.m., with stops in Segovia, Madrid, Cuenca, and Albacete.

Millions of individuals worldwide suffer from obesity, a chronic condition linked to a number of illnesses, including type 2 diabetes, hypertension, dyslipidaemia, and liver disease. Obesity has risen by 10% in the Valencian Community during the past ten years, impacting 14% of women and 19% of men. It is anticipated that between 55% and 80% of Spanish people will be overweight in less than five years.

“The approach to this pathology should not focus solely on weight loss, but on the overall improvement of the patient’s health and quality of life by consolidating a lasting change in habits,” says Dr. Carlos Sala, head of the Obesity Unit at Hospital Quirónsalud Valencia. In this sense, medications for obesity have created a therapeutic option as a short-term aid in a habit-change process.

Millions of individuals worldwide suffer from obesity, a chronic condition linked to a number of illnesses, including type 2 diabetes, hypertension, dyslipidaemia, and liver disease. Obesity has risen by 10% in the Valencian Community during the past ten years, impacting 14% of women and 19% of men. It is anticipated that between 55% and 80% of Spanish people will be overweight in less than five years.

“The approach to this pathology should not focus solely on weight loss, but on the overall improvement of the patient’s health and quality of life by consolidating a lasting change in habits,” says Dr. Carlos Sala, head of the Obesity Unit at Hospital Quirónsalud Valencia. In this sense, medications for obesity have created a therapeutic option as a short-term aid in a habit-change process.

Nowadays, people with a body mass index (BMI) of more than 28 who also have obesity-related conditions like type 2 diabetes or insulin resistance, high blood pressure, dyslipidaemia, hepatic steatosis, polycystic ovary syndrome, osteoarticular issues, or emotional disorders brought on by the failure of prior treatments are thought to be the best candidates for GLP-1 analogue medication.

“The main objective of these treatments,” says Dr. Jorge Cid, a specialist in the Endocrinology Department at Quirónsalud Torrevieja Hospital and Quirónsalud Alicante, “is not only weight loss, but also the improvement of metabolic status and associated diseases, ensuring that patients can maintain healthy habits once drug treatment has been discontinued.”

Dr. Sala cautions against using it in individuals who have already received unsuccessful treatment with GLP-1 analogues and have not seen a long-lasting change in their behaviour. Since bariatric and metabolic surgery has been demonstrated to be the most reliable and successful treatment for extreme obesity and its related conditions, it may be the best choice in these situations, he says.

Multidisciplinary monitoring
Dr. Sala notes that medication alone will not be sufficient for the effective treatment of obesity. “Success lies in its combination with personalised dietary and nutritional education, psychological support to modify the relationship with food, supervised physical exercise to improve body composition, and ongoing medical support to prevent relapse and weight gain,” according to the Quirónsalud Valencia Hospital specialist.

According to Dr. Cid, “clinical follow-up is essential to ensure that the patient does not sustain a long-term drug dependence.” Eight out of ten patients regain their weight without a well-planned approach, which emphasises the necessity of specialised medical care to meet long-term weight loss objectives.

Watch this video for more details about medication treatment for obesity: